"Landing" injection will bear the brunt of the price reduction of traditional Chinese medicine in the year

2013-11-13 source: Shanghai Securities News Shanghai Securities News reporter recently learned that the new round of price adjustment of traditional Chinese medicine "landed" within the year, the specific principle of adjustment is "there is a rise, there is a fall, there is a guarantee", and the following adjustments are the main ones According to Gan Rongfu, a senior industry researcher of Sinopharm holdings, "the price of exclusive varieties of traditional Chinese medicine, including those listed in the list of basic drugs, will also be reduced, even by more than 10%." it is worth noting that the adjustment of the price reduction to traditional Chinese medicine injection is likely to be the largest Shanghai Kaibao, Kunming Pharmaceutical, Zhongheng group and other listed companies with traditional Chinese medicine injection as their main products will be reduced Will usher in the performance test Since 1997, the national development and Reform Commission has launched 31 drug price adjustments Among them, the latest price reduction of chemicals involved 20 categories of drugs, more than 400 varieties and more than 700 representative dosage forms, with an average price reduction rate of 15%; while the latest price reduction of Chinese patent medicines was in 2009, when the overall price of more than 1000 basic drugs was reduced by 12% In June, the State Price Bureau began to investigate the cost and profit of some Chinese patent medicines In early November 2012, the national development and Reform Commission issued the notice on submitting the cost price and other information of some Chinese patent medicines, collecting the price information of Chinese patent medicines, making corresponding preparations in advance for the price evaluation of Chinese patent medicines, and preparing for the latest price adjustment of Chinese patent medicines According to a source from the price department of the national development and Reform Commission (NDRC) disclosed to the Shanghai Securities News, in the latest price adjustment of traditional Chinese medicine, the NDRC has studied a method different from that of chemical drugs, that is to say, there is a guarantee of rising and falling Among them, most of the prices of traditional Chinese medicine will be lowered; for some Chinese patent medicines whose prices are less than 5 yuan, as well as some medicines that can no longer guarantee production, the prices will remain stable or even increase An expert who attended the expert meeting on price adjustment of traditional Chinese medicine in Beijing last week told reporters that there are three conditions for the price increase: first, to reach the price that has been priced and published in 2010 Pharmacopoeia; second, the cost of traditional Chinese medicine accounts for more than 50% of the manufacturing cost, the main medicine is wild or perennial, has not yet realized large-scale cultivation and breeding, or is greatly affected by the address, climate and other factors, and nearly 5 "The company's traditional Chinese medicine products are exclusive varieties and may also encounter price reduction However, by entering the basic medicine catalog and strengthening the construction of basic channels, the sales volume will be rapidly boosted in the next year, which is enough to make up for the loss in price." Said the sales director of a Chinese medicine listed company The high gross profit margin of traditional Chinese medicine injection will be the main factor leading to its price reduction According to the financial reports of several related companies, the gross profit margin of Tanreqing injection of Shanghai Kaibao is 84.29%; that of Xueshuantong series of Zhongheng group is 85% Moreover, there is no lack of traditional Chinese medicine injection in the annual drug sales ranking For example, Danhong injection of step group has achieved an annual sales volume of 5 billion yuan; Xueshuantong of Zhongheng group ranked second in 2010, only lower than Plavix of Sanofi in Hangzhou "In the first half of the year, the revenue of Kunming Pharmaceutical Co., Ltd., which produces traditional Chinese medicine injection, increased by 18%, while the profit increased by 46%," a person in charge of the China Association of traditional Chinese medicine told the Shanghai Securities News that the high profit margin of traditional Chinese medicine injection will lead to the "most drastic" price reduction According to the insiders, the price of traditional Chinese medicine injection is too high, usually 2-3 times higher than that of other conventional dosage forms, and all links such as sales can benefit from it, which has opened a "green light" for the promotion and use of traditional Chinese medicine injection Moreover, since 100% of the inpatients can be reimbursed, Chinese medicine injection is widely used in inpatients In addition to increasing price management, the state will also tighten the examination and approval of new products for traditional Chinese medicine injections, not only new varieties are difficult to be approved, but also the safety re evaluation of old varieties will be carried out, a person from the traditional Chinese Medicine Department of the chamber of Commerce for medical insurance told reporters